Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
42
CPRX
Catalyst Pharmaceuticals
Last Price:
15.07
Seasonality Move:
5.15%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Catalyst Pharmaceuticals Price Quote
$15.07
-0.27 (-1.76%)
(Updated: April 19, 2024 at 3:00 PM ET)
Catalyst Pharmaceuticals Key Stats
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Day range:
$15.33 - $16.25
52-week range:
$11.09 - $17.77
Dividend yield:
0%
P/E ratio:
24.35
P/S ratio:
4.31
P/B ratio:
4.66%
Volume:
1.4M
Avg. volume:
1.2M
1-year change:
-13.92%
Market cap:
$1.8B
Revenue:
$398.2M
EPS:
$0.61
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $398.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $71.4M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.82% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.41%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went down by -4.6% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price fell by -13.92% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $17.77 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $11.09 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 27.77 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 27.00 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.00 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 19.24
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $137.6M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.62
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $143.6M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$10.9M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$293.5M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 20.45% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 16.92% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 20.45%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 15.34 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on May 10, 2024 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
Data Unavailable
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 40.91% | -37.41% |
| Revenue: | 81.98% | 4.39% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 26.71 |
| Upside from Last Price: | 74.15% |